Pharmaceutical challenges in veterinary product development

被引:1
|
作者
Ahmed, M [1 ]
Kasraian, K [1 ]
机构
[1] Pfizer Global Res & Dev, Groton, CT 06340 USA
关键词
veterinary drug delivery; controlled release; modified release; large animals; small animals;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many similarities between the human health and animal health industries. Both industries are research driven, have global presence, are highly regulated, and have to profit in a competitive business environment. However, there are also notable differences. This review highlights and discusses those differences as they relate to the pharmaceutical challenges in veterinary product development. This paper provides a brief review of the animal health pharmaceutical product landscape, segmentation, and market evolution; highlights challenges and special considerations in veterinary drug delivery; and identifies unmet needs in animal health along with recent advances. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:871 / 882
页数:12
相关论文
共 50 条
  • [41] Ontological informatics infrastructure for pharmaceutical product development and manufacturing
    Venkatasubramanian, Venkat
    Zhao, Chunhua
    Joglekar, Girish
    Jain, Ankur
    Hailemariam, Leaelaf
    Suresh, Pradeep
    Akkisetty, Pavankumar
    Morris, Ken
    Reklaitis, G. V.
    COMPUTERS & CHEMICAL ENGINEERING, 2006, 30 (10-12) : 1482 - 1496
  • [42] Pharmaceutical applications of cyclodextrins: basic science and product development
    Loftsson, Thorsteinn
    Brewster, Marcus E.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (11) : 1607 - 1621
  • [43] Multiobjective strategies for New Product Development in the pharmaceutical industry
    Perez-Escobedo, Jose L.
    Azzaro-Pantel, Catherine
    Pibouleau, Luc
    COMPUTERS & CHEMICAL ENGINEERING, 2012, 37 : 278 - 296
  • [44] Outsourcing in pharmaceutical research and development. opportunities and challenges
    Vikic-Topic, S
    CROATICA CHEMICA ACTA, 2005, 78 (03) : 333 - 336
  • [45] The veterinary pharmaceutical as a means and an end
    Vaarkamp, H
    Leemans, HCA
    Raymakers, RJML
    Schumer, DL
    Voermans, JJM
    TIJDSCHRIFT VOOR DIERGENEESKUNDE, 2000, 125 (19) : 586 - 592
  • [46] Challenges in the development of an efficient enzymatic process in the pharmaceutical industry
    Yazbeck, DR
    Martinez, CA
    Hu, SH
    Tao, JH
    TETRAHEDRON-ASYMMETRY, 2004, 15 (18) : 2757 - 2763
  • [47] Challenges and opportunities for the development of a national pharmaceutical policy in Mexico
    Wirtz, Veronika J.
    Dreser, Anahi
    Heredia-Pi, Ileana
    SALUD PUBLICA DE MEXICO, 2013, 55 (03): : 329 - 336
  • [48] Pharmaceutical Portfolio Development: Strategic Rationale, Challenges & Solutions
    Rao S.K.
    Journal of Commercial Biotechnology, 2022, 27 (03) : 1 - 10
  • [49] Pharmaceutical development of biologics: fundamentals, challenges and recent advances
    Su, Jing
    Mazzeo, Jeffrey
    Subbarao, Nanda
    Jin, Tuo
    THERAPEUTIC DELIVERY, 2011, 2 (07) : 865 - 871
  • [50] The availability of veterinary pharmaceutical products
    Buettner-Peter, Undine
    FLEISCHWIRTSCHAFT, 2008, 88 (01): : 97 - 99